Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App




Pioneering Analyzer with Advanced Biochip Technology Sets New Standard in Lab Diagnostics

By LabMedica International staff writers
Posted on 07 Jul 2025

A state-of-the-art analyzer combines advanced technology with exceptional efficiency to meet the demanding needs of modern laboratories. More...

Randox Toxicology (Antrim, Ireland) has launched its pioneering Evidence RABTA (Random Access Biochip Technology Analyzer), which combines advanced Biochip Array Technology with exceptional efficiency.

Biochip Array Technology is an immunoassay testing platform allowing for the simultaneous multi-analyte testing of a panel of related tests. The technology works by combining a panel of up to 48 tests on a single Biochip with a single set of reagents, controls, and calibrators. Competitive chemiluminescent immunoassays are employed for the Biochip Arrays. A light signal generated from each of the test regions on the Biochip is simultaneously detected using digital imaging technology and compared to that from a calibration curve. Available across a wide variety of matrices for forensic, clinical, and workplace toxicology, this revolutionary multi-analyte testing platform is designed to allow toxicologists to achieve a complete immunoassay profile in the initial screening phase.

Designed for seamless operation, the RABTA platform allows uninterrupted workflows and increased productivity. With rapid random-access capabilities, the analyzer provides precise and reliable results across a wide range of assays. Featuring five intuitive modules, this innovative analyzer simplifies high-throughput biological analysis, enabling clinicians to conduct complex assays quickly and accurately. Each module is tailored for specific functions, ensuring easy integration and adaptability for various applications, from diagnostics to advanced research. Its random-access capability allows simultaneous processing of multiple samples, making it an essential tool for modern laboratories.

Related Links:
Randox Toxicology 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
8-Channel Pipette
SAPPHIRE 20–300 µL
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.